SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-076888
Filing Date
2022-07-01
Accepted
2022-07-01 16:43:57
Documents
12
Period of Report
2022-06-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220294d1_8k.htm   iXBRL 8-K 27977
  Complete submission text file 0001104659-22-076888.txt   201804

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20220630.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20220630_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20220630_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2220294d1_8k_htm.xml XML 3605
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 221062046
SIC: 2834 Pharmaceutical Preparations